UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study

The Lancet. Haematology, 2015-10, Vol.2 (10), p.e408-e416

2015

Volltextzugriff (PDF)

Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews

Oncology and therapy, 2023-09, Vol.11 (3), p.303-312

2023

Volltextzugriff (PDF)

CRISPR-engineered T cells in patients with refractory cancer

Science (American Association for the Advancement of Science), 2020-02, Vol.367 (6481)

2020

Volltextzugriff (PDF)

Caregiving at the End of Life: Perceptions of Health Care Quality and Quality of Life Among Patients and Caregivers

Journal of pain and symptom management, 2006-05, Vol.31 (5), p.407-420

2006

Volltextzugriff (PDF)

Impact of EmbryoGlue as the embryo transfer medium

Fertility and sterility, 2008-07, Vol.90 (1), p.214-216

2008

Volltextzugriff (PDF)

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies

Journal of the advanced practitioner in oncology, 2017-04, Vol.8 (3), p.228-231

2017

Volltextzugriff (PDF)

Caregiving near the end of life: Unmet needs and potential solutions

Palliative & supportive care, 2003-09, Vol.1 (3), p.247-259

2003

Volltextzugriff (PDF)

Autologous hematopoietic stem cell transplantation for patients with multiple myeloma: an overview for nurses in community practice

Clinical journal of oncology nursing, 2013-12, Vol.17 Suppl (s6), p.13-24

2013

Volltextzugriff (PDF)

Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions

Clinical journal of oncology nursing, 2013-12, Vol.17 Suppl (s6), p.43-47

2013

Volltextzugriff (PDF)

Steroid-associated side effects in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board

Clinical journal of oncology nursing, 2008-06, Vol.12 (3 Suppl), p.53-62

2008

Volltextzugriff (PDF)

Post‐transplant outcomes of induction therapy for myeloma: Thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high‐dose melphalan with autologous stem cell support

American journal of hematology, 2007-12, Vol.82 (12), p.1071-1075

2007

Volltextzugriff (PDF)

Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board

Clinical journal of oncology nursing, 2008-06, Vol.12 (3 Suppl), p.9-12

2008

Volltextzugriff (PDF)

Circulating Multiple Myeloma Cells (CMMCs): A Novel Method for Detection and Molecular Characterization of Peripheral Blood Plasma Cells in Multiple Myeloma Precursor States

Blood, 2014-12, Vol.124 (21), p.2031-2031

2014

Volltextzugriff (PDF)

A Single-Center Retrospective Comparison of Post-Transplant Outcomes in Patients Receiving VRD Vs. VD Vs. RD As Initial Therapy Prior to ASCT for Newly Diagnosed Multiple Myeloma (MM)

Blood, 2012-11, Vol.120 (21), p.2042-2042

2012

Volltextzugriff (PDF)

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Final Results of a Phase 1 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Patients with Relapsed or Refractory Myeloma

Blood, 2011-11, Vol.118 (21), p.1869-1869

2011

Volltextzugriff (PDF)

Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma

Blood, 2009-11, Vol.114 (22), p.2146-2146

2009

Volltextzugriff (PDF)

Influenza (flu) Vaccine Administration to Patients with Multiple Myeloma (MM) Prior to Autologous T-Cell Harvest Leads to Better Reconstitution of Flu Immunity After High Dose Melphalan and Autologous Stem Cell Transplant (ASCT) and Reinfusion of Primed Ex-Vivo Co-Stimulated Autologous T-Cells and Post-ASCT Second Flu Vaccination Than Post-ASCT Flu Vaccination Alone

Blood, 2009-11, Vol.114 (22), p.797-797

2009

Volltextzugriff (PDF)

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Preliminary Results of a Phase 1/2 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Relapsed or Refractory Myeloma

Blood, 2008-11, Vol.112 (11), p.3684-3684

2008

Volltextzugriff (PDF)

Thalidomide and Dexamethasone Induction Therapy Is Associated with Superior Progression-Free Survival after Autotransplant for Myeloma

Blood, 2005-11, Vol.106 (11), p.1171-1171

2005

Volltextzugriff (PDF)

Long Term Follow-Up of 4-Hydroperoxycyclophosphamide Purged Autologous Bone Marrow Transplantation in Non-Hodgkin's Lymphoma Patients with High Risk of Bone Marrow Involvement

Blood, 2004-11, Vol.104 (11), p.5234-5234

2004

Volltextzugriff (PDF)

PERFORMANCE ASSESSMENT OF SENSORY PANELISTS

Journal of sensory studies, 1992-09, Vol.7 (3), p.229-252

MANGAN, PATRICIA A. PRITCHETT

1992

Volltextzugriff (PDF)

Cycles of Dose-Intensive Chemotherapy with Peripheral Stem Cell Support in Persistent or Recurrent Platinum-Sensitive Ovarian Cancer

Gynecologic oncology, 1997-12, Vol.67 (3), p.272-276

1997

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Humans
(35)
Life Sciences & Biomedicine
(35)
Female
(21)
Biological And Medical Sciences
(14)
Medical Sciences
(13)
Middle Aged
(12)
Male
(11)
Oncology
(11)
Nursing
(10)
Adult
(9)
Aged
(8)
Cancer
(8)
Care And Treatment
(8)
Diabetes
(8)
Hematology
(8)
United States
(8)
Multiple Myeloma
(7)
Stem Cell Transplantation
(7)
Hematology, Oncology And Palliative Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study

Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews

CRISPR-engineered T cells in patients with refractory cancer

Caregiving at the End of Life: Perceptions of Health Care Quality and Quality of Life Among Patients and Caregivers

Impact of EmbryoGlue as the embryo transfer medium

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

Caregiving near the end of life: Unmet needs and potential solutions

Transfer of influenza vaccine–primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial

Autologous hematopoietic stem cell transplantation for patients with multiple myeloma: an overview for nurses in community practice

Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions

Steroid-associated side effects in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board

Post‐transplant outcomes of induction therapy for myeloma: Thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high‐dose melphalan with autologous stem cell support

Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board

Circulating Multiple Myeloma Cells (CMMCs): A Novel Method for Detection and Molecular Characterization of Peripheral Blood Plasma Cells in Multiple Myeloma Precursor States

A Single-Center Retrospective Comparison of Post-Transplant Outcomes in Patients Receiving VRD Vs. VD Vs. RD As Initial Therapy Prior to ASCT for Newly Diagnosed Multiple Myeloma (MM)

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Final Results of a Phase 1 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Patients with Relapsed or Refractory Myeloma

Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Preliminary Results of a Phase 1/2 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Relapsed or Refractory Myeloma

Thalidomide and Dexamethasone Induction Therapy Is Associated with Superior Progression-Free Survival after Autotransplant for Myeloma

Long Term Follow-Up of 4-Hydroperoxycyclophosphamide Purged Autologous Bone Marrow Transplantation in Non-Hodgkin's Lymphoma Patients with High Risk of Bone Marrow Involvement

PERFORMANCE ASSESSMENT OF SENSORY PANELISTS

Cycles of Dose-Intensive Chemotherapy with Peripheral Stem Cell Support in Persistent or Recurrent Platinum-Sensitive Ovarian Cancer

Suchergebnisse filtern